GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » 3-Year Revenue Growth Rate

Genscript Biotech (HKSE:01548) 3-Year Revenue Growth Rate : 24.90% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech 3-Year Revenue Growth Rate?

Genscript Biotech's Revenue per Share for the six months ended in Dec. 2023 was HK$1.66.

During the past 12 months, Genscript Biotech's average Revenue per Share Growth Rate was 33.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 10 years, the highest 3-Year average Revenue per Share Growth Rate of Genscript Biotech was 32.20% per year. The lowest was 21.50% per year. And the median was 26.40% per year.


Competitive Comparison of Genscript Biotech's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Genscript Biotech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genscript Biotech's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's 3-Year Revenue Growth Rate falls into.



Genscript Biotech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Genscript Biotech  (HKSE:01548) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Genscript Biotech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Genscript Biotech (HKSE:01548) Business Description

Traded in Other Exchanges
Address
No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100
GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines